Tag Archives: Just

Hey, naysayers: Bristol-Myers’ Celgene buy just chalked up another point in its favor

Bristol-Myers Squibb scored more bragging rights for its coming megamerger: The FDA is now officially reviewing one of the “Big 5” Celgene candidates touted as cornerstones of the deal. And it’s ozanimod, the blockbuster MS prospect whose application the FDA wouldn’t even consider last year. Regulators in both the U.S. and Europe accepted Celgene’s ozanimod filings to… Read More »

Viewpoints: Defunding Title X-Funded Health Centers Will Undermine Efforts To End HIV Crisis; Help The Homeless, Don’t Just Lock Them Up

Opinion writers weigh in on these health topics and others The Hill: Trump’s Gag Rule Jeopardizes Preventative Care For Women Title X-funded health centers also serve as the point of entry into the health care system for millions of Americans – the majority of women cite these health centers as their sole source of care,… Read More »